Uncertain future clinical performance and environmental risk factors (e.g., competitive, regulatory, pricing, and market access) combine to raise the level of difficulty in developing product forecasts. In these situations, rather than focusing on point forecast estimates, communicating the range of possible forecast outcomes and their likelihood provides a more useful foundation for decision-making. In this webinar we outline approaches for incorporating risk in early-stage forecasts.